The global intrauterine devices market was valued at $2,992.73 million in 2021 and is projected to reach $4,374.3 million by 2031, registering a CAGR of 3.8% from 2022 to 2031. An intrauterine device (IUD) is a small plastic T-shaped device used for birth control. It is inserted into the uterus where it stays to prevent pregnancy. The intrauterine device is one form of long-acting reversible birth control (LARC) that is also safe and effective in adolescents as well as those who have not previously had children. Once an intrauterine device is removed, even after long-term use, fertility returns to normal rapidly. There are two types of intrauterine devices available on the market including nonhormonal: copper-containing IUD and hormonal: progestogen-releasing IUD to prevent unwanted pregnancies.
The global intrauterine devices market is segmented on the basis of type, age group, end-user, and region. Based on type, the market is classified into nonhormonal: copper-containing IUDs and hormonal: progestogen-releasing IUDs. By age group, it is categorized into 15-24 years, 25-34 years, 35-44 years, and above 44 years. By end-user, it is classified into hospitals, community health centers, clinics, and others. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The major factors that drive the growth of the market are an increase in focus on family planning and the need for preventing unintended pregnancy. The advancement in hormonal intrauterine devices with enhanced efficacy and fewer side effects are expected to further boost the market growth. Moreover, health issues associated with teenage pregnancies, an increase in awareness of intrauterine device methods method to prevent unplanned pregnancy fuel the market growth. However, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect the market growth.
The key players operating in the global intrauterine devices market include the AbbVie Inc.(Allergan Plc) , Bayer AG, Cooper Companies Inc, DKT International, Mona Lisa NV ( EurimPharma Group) , Ocon Healthcare, Pregana International Ltd, Prosan International B.V. Eurogine SL and Viatris Inc. (Mylan NV).
In 2021, Asia Pacific was the major revenue generator, owing to the presence of a large population, increase in awareness of the benefits of using hormonal intrauterine devices, high prevalence of unwanted pregnancy, and favorable regulatory scenario. However, North America is the second-largest revenue generator in 2021, due to the presence of. healthcare infrastructure and rising awareness pertaining to the usage of IUDs.
The global intrauterine devices market is segmented on the basis of type, age group, end-user, and region. Based on type, the market is classified into nonhormonal: copper-containing IUDs and hormonal: progestogen-releasing IUDs. By age group, it is categorized into 15-24 years, 25-34 years, 35-44 years, and above 44 years. By end-user, it is classified into hospitals, community health centers, clinics, and others. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The major factors that drive the growth of the market are an increase in focus on family planning and the need for preventing unintended pregnancy. The advancement in hormonal intrauterine devices with enhanced efficacy and fewer side effects are expected to further boost the market growth. Moreover, health issues associated with teenage pregnancies, an increase in awareness of intrauterine device methods method to prevent unplanned pregnancy fuel the market growth. However, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect the market growth.
The key players operating in the global intrauterine devices market include the AbbVie Inc.(Allergan Plc) , Bayer AG, Cooper Companies Inc, DKT International, Mona Lisa NV ( EurimPharma Group) , Ocon Healthcare, Pregana International Ltd, Prosan International B.V. Eurogine SL and Viatris Inc. (Mylan NV).
In 2021, Asia Pacific was the major revenue generator, owing to the presence of a large population, increase in awareness of the benefits of using hormonal intrauterine devices, high prevalence of unwanted pregnancy, and favorable regulatory scenario. However, North America is the second-largest revenue generator in 2021, due to the presence of. healthcare infrastructure and rising awareness pertaining to the usage of IUDs.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intrauterine devices market analysis from 2021 to 2031 to identify the prevailing intrauterine devices market opportunities.
- Market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the intrauterine devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global intrauterine devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Nonhormonal: Copper-containing IUD
- Hormonal: Progestogen-releasing IUD
By Age Group
- 25-34 years
- 35-44 years
- Above 44 years
- 15-24 years
By End User
- Hospitals
- Clinics
- Community Health Care Centres
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Bayer AG
- CooperSurgical Inc
- DKT International
- Mona Lisa NV
- Pregna International Limited
- Prosan International BV
- Abviee Inc
- Eurogine, S.L.
- Viatris Inc
- Mona Lisa N.V.,
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: INTRAUTERINE DEVICES MARKET, BY TYPE
CHAPTER 5: INTRAUTERINE DEVICES MARKET, BY AGE GROUP
CHAPTER 6: INTRAUTERINE DEVICES MARKET, BY END USER
CHAPTER 7: INTRAUTERINE DEVICES MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Intrauterine Devices Market," the Intrauterine Devices Market Size was valued at $3.0 billion in 2021, and is estimated to reach $4.4 billion by 2031, growing at a CAGR of 3.8% from 2022 to 2031.An Intrauterine device is a small, plastic T-shaped device that is placed inside the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops) to prevent pregnancy. Intrauterine devices prevent sperm from fertilizing an egg and prevent fertilized eggs from implanting in the uterus. The global Intrauterine Devices Market Size was valued at $2,992.73 million in 2021 and is projected to reach $4,374.3 million by 2031, registering a CAGR of 3.8% from 2022 to 2031.
The Intrauterine Devices Market Trends that drive the growth of the market are an increase in focus on family planning, health issues associated with teenage pregnancies, increase in awareness about hormonal uterine device methods, which are key methods to prevent unplanned pregnancy. Advancing intrauterine hormonal devices with better efficacy and fewer side effects further boost market growth. However, the availability of alternate contraceptive methods, health risks associated with the use of hormonal intrauterine devices, and lack of social acceptance adversely affect the market growth.
COVID-19 Impact
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has a high potential of lethality in the geriatric population. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as a pandemic. In addition, only a few vaccines received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global intrauterine device market. Owing to the decline in the number of patient visits for contraception in hospitals as intrauterine devices market is majorly dependent on physician-administered and physician-prescribed. However, during the first few months of the ongoing pandemic, restrictions pertaining to physician office visits without an emergency were established. Furthermore. Half of the population who are thinking about family planning during COVID-19 has shifted their interest from intrauterine devices to other contraception methods such as contraception pills which led to a decline in the demand for intrauterine device products across the world.
The Intrauterine Devices Market analysis is done on the basis of type, age group, end-user, and geography. Based on type, the market is classified into nonhormonal: copper-containing IUD and hormonal: progestogen-releasing IUDs. By age group, it is categorized into 15-24 years, 25-34 years, 35-44 years, and above 44 years. By end-user, it is classified into hospitals, community health centers, clinics, and others. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA
Among the type, the hormonal: progestogen-releasing IUD segment has dominated the market in 2021, as these devices are easily available and have a high success rate of up to 99% to prevent pregnancy. However, nonhormonal: copper-containing IUD registers the highest growth rate, due to the ease of usage and fewer side effects caused by it.
By age group, the 25-34 years segment has higher Intrauterine Devices Market Share in 2021, owing to the increase in the prevalence of unwanted pregnancies and the rise in family planning across the world drives the growth of the market.
By end-user. hospitals accounted for the largest share of the market in 2021, owing to a rise in the number of patients visiting for family planning drives the growth of the market in the upcoming year.
The key players operating in the global Intrauterine Devices Industry include Abbvie Inc.(Allergan Plc), Bayer AG, Cooper Companies Inc, DKT International, Mona Lisa NV (EurimPharma Group), Ocon Healthcare, Pregana International Ltd, Prosan International B.V. and Viatris Inc. (Mylan NV).
In 2021, Asia Pacific was the major revenue generator, owing to an increase in awareness of the benefits of using hormonal intrauterine devices, the high prevalence of unwanted pregnancy, and favorable regulatory scenarios. However, North America is the second-largest revenue generator in Intrauterine Devices Industry, due to the presence. healthcare infrastructure and rising awareness pertaining to the usage of IUDs.
Key Findings of the Study
- By type, the hormonal: progestogen-releasing IUD segment was the highest contributor to the market in 2021.
- By age group, the25-34 years segment has dominated the market in 2021.
- On the basis of end-user, the hospital segment has dominated the market in 2022 and is expected to continue this trend during the forecast period.
- Region-wise, Asia Pacific garnered the largest revenue share in 2021; however, North America is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Bayer AG
- Coopersurgical Inc
- Dkt International
- Mona Lisa Nv
- Pregna International Limited
- Prosan International Bv
- Abviee Inc
- Eurogine, S.L.
- Viatris Inc
- Mona Lisa N.V.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 245 |
| Published | June 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2992.73 million |
| Forecasted Market Value ( USD | $ 4374.3 million |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
